This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2019 - 2022)
- Kanagawa, JP (2022 - 2024)
Company Filing History:
Years Active: 2019-2025
Title: Hiromichi Sugimoto: Innovating the Future of Sleep Medicine
Introduction
Hiromichi Sugimoto is an accomplished inventor based in Tokyo, Japan, recognized for his significant contributions to the pharmaceutical industry. With a total of six patents to his name, Sugimoto is advancing the field of sleep medicine through his innovative research and development efforts.
Latest Patents
Among his recent works, Sugimoto has focused on the discovery of heterocyclic compounds with orexin type 2 receptor agonist activity. His inventions aim to provide therapeutic solutions for narcolepsy, a condition characterized by excessive daytime sleepiness. The compounds he has developed, as described by specific formulas in his patents, are poised to play a crucial role in both the prophylaxis and treatment of this challenging disorder.
Career Highlights
Sugimoto's career is marked by his association with Takeda Pharmaceutical Company Limited, where he has made significant strides in drug development. His innovative spirit and dedication to research have positioned him as a key figure in the company and the broader pharmaceutical community.
Collaborations
Throughout his career, Sugimoto has collaborated with talented professionals such as Tatsuhiko Fujimoto and Kentaro Rikimaru. These partnerships highlight the collaborative nature of research and innovation, as they work together to push the boundaries of what's possible in medical science.
Conclusion
Hiromichi Sugimoto's contributions to the field of sleep medicine underscore the vital role of innovation in addressing complex medical challenges. His patented inventions not only reflect his expertise but also promise to improve the lives of many suffering from narcolepsy. As ongoing research continues to unfold, Sugimoto's work remains at the forefront of pharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
